Emergent BioSolutions
EBS
#6851
Rank
NZ$1.04 B
Marketcap
NZ$19.65
Share price
-2.65%
Change (1 day)
33.71%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): NZ$0.28 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are NZ$0.75 Billion. In 2024 the company made an earning of -NZ$0.13 Billion, an increase over its 2023 earnings that were of -NZ$1.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.28 B-333.31%
2024 -NZ$0.13 Billion-88.82%
2023 -NZ$1.11 Billion242.73%
2022 -NZ$0.33 Billion-153.8%
2021 NZ$0.60 B-20.43%
2020 NZ$0.75 B278.02%
2019 NZ$0.19 B27.11%
2018 NZ$0.15 B-27.12%
2017 NZ$0.21 B17.21%
2016 NZ$0.18 B0.45%
2015 NZ$0.18 B73.51%
2014 NZ$0.10 B41.36%
2013 NZ$74.67 M35.2%
2012 NZ$55.23 M0.4%
2011 NZ$55.01 M-56.46%
2010 NZ$0.12 B76.73%
2009 NZ$71.49 M32.94%
2008 NZ$53.77 M-5.62%
2007 NZ$56.98 M
2005 NZ$82.5 M269.89%
2004 NZ$22.3 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
NZ$39.76 B 13,868.54%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.15 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.05 B 5,539.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-NZ$0.45 Billion-255.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.40 B 7,069.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.05 B 971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-NZ$21.3 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA